VICAL INC Uncategorized Contracts & Agreements
31 Contracts & Agreements
- Plan of Dissolution of Fresh Tracks Therapeutics, Inc (Filed With SEC on September 19, 2023)
- Second Amendment to Rights Agreement, dated as of July 21, 2023, by and among Fresh Tracks Therapeutics, Inc., Brickell Subsidiary, Inc., and Bodor Laboratories, Inc (Filed With SEC on July 21, 2023)
- Letter Agreement, dated as of May 4, 2023, by and between Fresh Tracks Therapeutics, Inc. and BRE-BMR Flatiron VII LLC (f/k/a GPIF 5777 Flatiron LLC and BMC Properties, LLC) (Filed With SEC on May 10, 2023)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Exchange Act (Filed With SEC on March 30, 2023)
- Amendment to Rights Agreement, dated as of November 10, 2022, by and among Fresh Tracks Therapeutics, Inc., Brickell Subsidiary, Inc. and Bodor Laboratories, Inc (Filed With SEC on November 14, 2022)
- Rights Agreement, dated as of May 3, 2022, by and among Brickell Biotech, Inc., Brickell Subsidiary, Inc., and Bodor Laboratories, Inc (Filed With SEC on May 3, 2022)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Exchange Act (Filed With SEC on March 15, 2022)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Exchange Act (Filed With SEC on March 9, 2021)
- Letter Agreement, dated as of September 3, 2020, by and between Brickell Biotech, Inc. and Kaken Pharmaceutical Co., Ltd (Filed With SEC on October 13, 2020)
- Brickell Biotech, Inc. Letter Agreement, dated July 10, 2018 by and between Brickell Biotech Inc. and Jose Breton (Filed With SEC on September 3, 2019)
- Right of First Negotiation Agreement, as amended, dated March 31, 2015, by and between Brickell Biotech, Inc. and Kaken Pharmaceutical Co., Ltd (Filed With SEC on September 3, 2019)
- Form of Lock-Up Agreement, dated June 2, 2019, by each of the parties named in each agreement therein (Filed With SEC on June 3, 2019)
- Form of Support Agreement, dated June 2, 2019, by and between the Company and each of the parties named in each agreement therein (Filed With SEC on June 3, 2019)
- AMENDMENT No.1 (Filed With SEC on October 30, 2015)
- 10390 Pacific Center Court, San Diego, CA92121-43408586461100, FAX: 8586461150www.vical.com (Filed With SEC on August 22, 2013)
- EXHIBIT A OPTION TERMS (Filed With SEC on March 15, 2013)
- Vical Incorporated Non-Employee DirectorCompensation Policy (Filed With SEC on February 25, 2010)
- Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20th Floor, New York, NY 10020 (Filed With SEC on May 22, 2009)
- FIRST AMENDMENT TO (Filed With SEC on November 9, 2007)
- VICAL INCORPORATED 10390 Pacific Center Court (Filed With SEC on November 9, 2006)
- VICAL INCORPORATED 10390 Pacific Center Court (Filed With SEC on August 7, 2006)
- VICAL INCORPORATED 10390 Pacific Center Court (Filed With SEC on August 7, 2006)
- 4,704,000 Shares (Filed With SEC on October 12, 2005)
- VICAL INCORPORATED 10390 Pacific Center Court San Diego, CA 92121-4340 April 15, 2005 (Filed With SEC on May 10, 2005)
- SECURITYAGREEMENT (Securities) Dated as of March 19, 2004 (Filed With SEC on May 10, 2004)
- VICAL INCORPORATED 10390 Pacific Center Court San Diego, CA 92121-4340 March 15,2004 (Filed With SEC on March 24, 2004)
- 3,379,000 Shares VICAL INCORPORATED (Filed With SEC on March 24, 2004)
- SOLICITATION (Filed With SEC on March 11, 2004)
- VICAL INCORPORATED 9373 Towne Centre Drive Suite 100 San Diego, CA 92121 March 10, 2003 (Filed With SEC on March 31, 2003)
- to the Research, Option and LicenseAgreement dated September 29, 1994 (Filed With SEC on March 31, 2003)
- INDEMNITY AGREEMENT (Filed With SEC on March 31, 2003)
